Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.261/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.261 |
Version | 20231101 |
Status | active |
Date | 2023-11-01T01:03:22-04:00 |
Name | HeartFailureCHF_HCPCS |
Title | Heart Failure (CHF)_HCPCS |
Experimental | False |
Realm | us |
Authority | hl7 |
Description | b.well created value set by Sr. Clinical Business Analyst for CHF Condition. |
Purpose | (Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute CHF Condition for inclusion and utilization in patients/users connected heath.),(Data Element Scope: CHF Condition for b.well.),(Inclusion Criteria: CHF HCPCS Codes that constitute the CHF Condition for b.well.),(Exclusion Criteria: N/A) |
ValueSet | |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.265 ![]() | Heart Failure (CHF)_Clinical Condition Grouping |
No resources found
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1235.261",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "B.well Connected Health Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-11-06"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-11-01"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.261",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1235.261"
}
],
"version" : "20231101",
"name" : "HeartFailureCHF_HCPCS",
"title" : "Heart Failure (CHF)_HCPCS",
"status" : "active",
"date" : "2023-11-01T01:03:22-04:00",
"publisher" : "B.well Connected Health Steward",
"description" : "b.well created value set by Sr. Clinical Business Analyst for CHF Condition.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute CHF Condition for inclusion and utilization in patients/users connected heath.),(Data Element Scope: CHF Condition for b.well.),(Inclusion Criteria: CHF HCPCS Codes that constitute the CHF Condition for b.well.),(Exclusion Criteria: N/A)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"concept" : [
{
"code" : "C9758",
"display" : "Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study"
},
{
"code" : "C9760",
"display" : "Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:5963d4bd-8046-4a55-89a8-dc59c3138204",
"timestamp" : "2024-12-10T08:48:24-05:00",
"total" : 2,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "C9758",
"display" : "Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "C9760",
"display" : "Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.